Founded in 2015, ORI Capital is a healthcare venture capital firm that invests in innovative early-stage biotech companies globally. ORI Capital leverages a proprietary quantimental strategy combining AI assisted big data with fundamental research and an experienced team of healthcare specialists to invest in the areas of diagnostics, drug delivery, and therapeutics focused on disease areas with the highest mortality rates including cancer, cardiovascular, and neurodegenerative diseases. ORI Capital’s mission is to be both financially successful for its investors and socially impactful for patients worldwide.